Back

Real-world performance of current sudden cardiac death risk stratification tools in hypertrophic cardiomyopathy: a single-centre study

10 May 2026 (16:30 - 17:15)
Organised by: Logo
Congress Presentation Part of: Sudden cardiac death, ventricular arrhythmias, and emerging treatment strategies Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Helena Santos Moreira

Sao Joao University Hospital Centre, Porto (Portugal)

5 More presentations in this session

Presentation thumbnail
Sudden cardiac death in young adults: a contemporary 5 year observational cohort study from a tertiary cardiology center
Doctor T. Barboi (Bucharest, RO)
Abstract Slides
Presentation thumbnail
Electrocardiographic features associated with genetic positivity in brugada syndrome
Doctor B. Lage Garcia (Guimaraes, PT)
Abstract Slides
Presentation thumbnail
Catheter ablation to reduce cardiovascular hospitalizations in patients with ventricular arrhythmias: a systematic review and meta-analysis of randomized controlled trials
Doctor M. Grine (Coimbra, PT)
Abstract Slides
Presentation thumbnail
Intravenous dantrolene for class iii antiarrhythmic drug resistant refractory ventricular arrhythmias in patients with heart failure: final results of a phase ii study
Doctor J. Nawata (Ube, JP)
Abstract Slides
Presentation thumbnail
Real-world applicability of a risk prediction score in apical hypertrophic cardiomyopathy
Doctor H. Santos Moreira (Porto, PT)
Abstract Slides

Access the full session

Session thumbnail
Sudden cardiac death, ventricular arrhythmias, and emerging treatment strategies

The Event

Event poster

Heart Failure 2026

10 May 2026 16:30 CET
You may be interested in
thumbnail
Congress Session
Risk assessment and prevention of sudden cardiac death in cardiomyopathies
thumbnail
Webinar
The role of cardiac magnetic resonance for patients with ventricular arrhythmias and the prevention of sudden cardiac death in light of the 2022 ESC Guidelines
thumbnail
Congress Session
Gaps in risk stratification for patients with structural heart disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources